BALSAMIC LINIMENT (BY VISHNEVSKY)

INSTRUCTIONS FOR MEDICAL USE OF THE MEDICINAL PRODUCT BALSAMIC LINIMENT (BY VISHNEVSKY)

Composition:

Active ingredients: birch tar, ichthammol;

1 g of liniment contains birch tar – 30 mg, ichthammol – 30 mg;

Excipients: colloidal anhydrous silicon dioxide, castor oil.

Pharmaceutical form. Liniment.

Main physicochemical properties: homogeneous liniment of light yellow to brown color with a specific odor.

Pharmacotherapeutic group.
Antiseptics and disinfectants. ATC code D08A X.

Pharmacological properties.

Pharmacodynamics.

The drug exerts a mild disinfectant, astringent, and local irritant effect. Due to its mild irritant action on tissue receptors, it promotes acceleration of the regeneration process by normalizing tissue circulation and enhancing keratinization of the epidermis.

Clinical characteristics.

Indications.

Abscesses, furuncles, pressure sores, lymphadenitis, lymphangitis, burns, frostbite, trophic ulcers.

Contraindications.

Hypersensitivity to coal tar, xeroform, or to other components of the drug.

Interaction with other medicinal products and other forms of interaction.

When used simultaneously with topical agents, new compounds may form, resulting in unpredictable effects.

Special precautions for use.

The liniment is intended for external use only. Before applying a dressing, the wound should be cleaned from necrotic tissues, blisters should be opened, and the wound should be rinsed with an antiseptic solution.

Avoid contact of the liniment with mucous membranes. After application, hands should be thoroughly washed to prevent accidental transfer of residual ointment to the eyes, nose, or mouth. In case of contact, rinse thoroughly with large amounts of water.

Birch tar contained in the balsamic liniment may increase sensitivity to sunlight; therefore, during summer, exposure to direct sunlight should be avoided while using this product.

If symptoms do not begin to improve, or if the patient's condition worsens or adverse reactions occur, the use of the product must be discontinued and medical advice should be sought for further therapy.

Use during pregnancy or breastfeeding.

Since the safety and clinical efficacy of the product during pregnancy or breastfeeding have not been studied, it should only be used if the benefit outweighs the potential risk.

Ability to influence reaction rate when driving or operating machinery.

The effect of the product on the ability to drive or operate machinery has not been reported.

Method of Administration and Dosage

For adults, apply the ointment externally: apply to affected areas of the skin. On wounds, apply a sterile dressing or sterile bandage soaked with the medication. Change the dressing every 2–3 days. Treatment duration is 6 to 20 days.

Children

The medication must not be used in children.

Overdose

Not described.

Side effects.

Allergic reactions (including skin rash, itching). With prolonged use, skin irritation is possible.

Shelf life. 5 years.

Storage conditions.

Store in the original packaging at a temperature not exceeding 25 °C. Keep out of reach of children.

Packaging.

Containers of 25 g and 50 g; aluminum tubes of 20 g, 25 g, and 40 g in a carton or without a carton; laminated tubes of 20 g, 25 g, and 40 g in a carton or without a carton.

Dispensing category. Over-the-counter.

Manufacturer: JSC Pharmaceutical Factory "Viola".

Manufacturer's address:

75 Amosova Akademika Street, Zaporizhzhia, 69063, Ukraine.

Marketing Authorization Holder: JSC Pharmaceutical Factory "Viola".

Address of the Marketing Authorization Holder:

75 Amosova Akademika Street, Zaporizhzhia, 69063, Ukraine.